US Patent Granted on Antibodies Against GM-CSF to Treat Inflammatory Disorders

MorphoSys AG and the University of Melbourne announced today that the USPTO has confirmed that it will issue U.S. Patent No. 7,455,836, covering key uses of antibodies against GM-CSF.

The details can be read here.